Schedule & Agenda

Below is the 2019 program at the BIO Investor Forum. The 2020 schedule will be updated summer 2020.

BIO Investor Forum
Date
Time
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO Investor Forum
Jump to Day
50 Results
Tuesday, October 22
9:00 AM - 9:15 AM (EDT)
Kymeris Therapeutics is late Discovery Stage firm with an effective Solid Cancer Immunotherapy…
9:30 AM - 9:45 AM (EDT)
Riptide is a late preclinical-stage biotechnology company developing novel peptide therapeutics for…
10:00 AM - 10:15 AM (EDT)
Cytovia is dedicated to the development of transformational cancer immunotherapies, addressing…
We are an early stage research company developing a platfrom for the detection and treatment of…
Kineta, Inc. is a clinical stage biotechnology company committed to developing disruptive life…
10:15 AM - 10:30 AM (EDT)
OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. Our…
10:30 AM - 10:45 AM (EDT)
ImmunoMet is a clinical stage biotech targeting cellular metabolism to develop novel anti-tumor and…
Founded in 2017, RubrYc Therapeutics, Inc. integrates massively parallel in silico simulation and…
10:45 AM - 11:00 AM (EDT)
BridGene is a Biotech company founded by Dr. Chao Zhang based on his well recognized research in…
11:00 AM - 11:15 AM (EDT)
Zenopharm is a startup founded in 2012 to commercialize innovative oncology therapeutics based on…
11:15 AM - 11:30 AM (EDT)
Sapience Therapeutics is focused on discovering and developing peptide-based therapeutics to…
11:30 AM - 11:45 AM (EDT)
Nammi Therapeutics utilizes nanocarriers to deliver synergistic anti-tumor and immunomodulatory…
2:15 PM - 2:30 PM (EDT)
Greenwich LifeSciences (GLS) is a private biopharmaceutical company located in Houston, TX that is…
The Company is engaged in the clinical development of its novel small molecule, PT-112, a first-in…
2:30 PM - 2:45 PM (EDT)
AIMM is an antibody company which selects functional antibodies directly from cured cancer patients…
Kleo Pharmaceuticals is a unique immuno-oncology company developing next-generation bispecific…
SynDevRx is a clinical-stage biotech company developing drug candidates to treat cancers driven by…
3:00 PM - 3:15 PM (EDT)
Actinium Pharmaceuticals Inc. is focused on improving patient access and outcomes to cellular…
Incysus is focused on delivering a novel off-the-shelf cell therapy for the treatment of cancer. By…
3:15 PM - 3:30 PM (EDT)
BioMarker Strategies is a privately held molecular diagnostics company founded in 2006 at The Johns…
Pacylex is a Canadian oncology company exploiting a new discovery in cancer biology which may…
3:30 PM - 3:45 PM (EDT)
TheraTarget holds the patent and licensing rights for a widely applicable polymer-anti-cancer agent…
3:45 PM - 4:00 PM (EDT)
We are a UK-based injectable GnRH company that is looking to go to Phase 3 trials in prostate…
Orion Biotechnology is a clinical stage Canadian Biotechnology company with operations in…
4:00 PM - 4:15 PM (EDT)
Penetration of anti-cancer agents into and throughout solid tumours is widely recognised as…
SyntheX uses synthetic biology to create the next generation of drug discovery platforms for…
Wednesday, October 23
9:00 AM - 9:15 AM (EDT)
Mantra Bio is a therapeutics company harnessing exosomes for highly targeted in vivo delivery…
9:15 AM - 9:30 AM (EDT)
NaNotics, LLC is a privately held company based in Mill Valley, CA, currently raising a Series B…
Phanes Therapeutics is an emerging leader in innovative discovery research in the immuno-oncology…
9:30 AM - 9:45 AM (EDT)
VM Oncology, a clinical-stage precision oncology company, is currently developing a first-of-its…
9:45 AM - 10:00 AM (EDT)
ACT Genomics is a leading molecular information company, integrating clinical grade next-generation…
10:00 AM - 10:15 AM (EDT)
Vigeo Therapeutics is a clinical-stage biopharmaceutical company developing novel therapeutics that…
10:30 AM - 10:45 AM (EDT)
Immunotherapy is revolutionizing cancer treatment. By activating a patient’s own immune system to…
Oncolytics is a biotechnology company developing pelareorep, an intravenously delivered immuno…
10:45 AM - 11:00 AM (EDT)
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange. Foresee’s…
InterVenn Biosciences utilizes a proprietary glycoproteomic biomarker interrogation platform using…
11:00 AM - 11:15 AM (EDT)
NeOnc Technologies, Inc. (NTI) is a Phase 2 cancer biotechnology company focused on intranasal …
11:15 AM - 11:30 AM (EDT)
Golden Biotechnology Corporation (GBC), founded in 2002, is a leading innovative drug discovery and…
11:30 AM - 11:45 AM (EDT)
TVAX Biomedical is a privately held cancer immunotherapy company planning a Ph 2b pivotal study in…
Zenith Epigenetics Ltd. is a clinical stage biotechnology company developing best in class…
2:00 PM - 2:15 PM (EDT)
Boundless Bio, a San Diego based company backed by ARCH Venture Partners, City Hill Ventures,…
IMV Inc. is a clinical stage biopharmaceutical company dedicated to making immunotherapy more…
2:15 PM - 2:30 PM (EDT)
Bipharm is an innovative preclinical stage biotech company developing potent small molecules that…
2:30 PM - 2:45 PM (EDT)
Oragenics, Inc. is focused on becoming a leader in novel antibiotics against infectious disease…
Rakuten Medical is a privately funded, clinical-stage biotechnology company with offices in the U.S…
2:45 PM - 3:00 PM (EDT)
MAIA Biotechnology, Inc. is a cutting-edge, early stage biotech company, dedicated to developing…
Xenetic Biosciences, Inc. (NASDAQ: XBIO) is a biopharmaceutical company focused on progressing…
3:00 PM - 3:15 PM (EDT)
DotBio focuses on the development of multi-functional antibodies with synergistic activities to…
Impact Therapeutics is a privately held clinical-stage biopharmaceutical company incorporated in…
3:15 PM - 3:30 PM (EDT)
xCella Biosciences is an integrated oncology drug discovery and development company combining…